Christopher O'Reilly | IR |
Christophe Weber | President, CEO & Representative Director |
Andrew Plump | President, Research & Development and Director |
Constantine Saroukos | CFO & Director |
Julie Kim | President, Plasma-Derived Therapies Business Unit |
Fumiyoshi Sakai | Crédit Suisse |
Hidemaru Yamaguchi | Citigroup |
Kazuaki Hashiguchi | Daiwa Securities |
Shinichiro Muraoka | Morgan Stanley |
Akinori Ueda | Goldman Sachs Group |
Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. [Operator Instructions].
Now we start the conference. Mr. O'Reilly, please go ahead.